title: [Cytosar in the treatment of hematosarcomas].
authors.forename: G V
authors.initials: GV
authors.lastname: Kruglova
authors.forename: I A
authors.initials: IA
authors.lastname: Finogenova
authors.forename: A F
authors.initials: AF
authors.lastname: Shramko
authors.forename: E G
authors.initials: EG
authors.lastname: Bragina
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D003561:Cytarabine
vernacular_title: Tsitozar v lechenii gematosarkom.